Blood Cancers Completed Phase 1 / 2 Trials for Darbepoetin alfa (DB00012)

Also known as: Blood Cancer

IndicationStatusPhase
DBCOND0048268 (Blood Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00230321A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)Treatment